Subtopic Deep Dive
Carbapenemases
Research Guide
What is Carbapenemases?
Carbapenemases are β-lactamase enzymes produced by Gram-negative bacteria that hydrolyze carbapenem antibiotics, conferring resistance to last-resort treatments like meropenem and imipenem.
Major types include serine-based KPC, metallo-β-lactamases like NDM-1, and OXA enzymes. They spread via plasmids in Enterobacteriaceae such as Klebsiella pneumoniae. Over 20,000 papers reference carbapenemases, with foundational work on NDM-1 exceeding 2,300 citations (Yong et al., 2009).
Why It Matters
Carbapenemase-producing bacteria cause untreatable infections in hospitals, with NDM-1 emerging in India and spreading globally (Kumarasamy et al., 2010; Nordmann et al., 2011). They threaten last-resort antibiotics, driving surveillance via databases like CARD (Alcock et al., 2019). Infections linked to KPC and NDM raise mortality rates by 40-50% in ICU settings, fueling global resistance crises (Walsh et al., 2010).
Key Research Challenges
Global Plasmid-Mediated Spread
Carbapenemase genes like bla_NDM-1 transfer via conjugative plasmids across Enterobacteriaceae, evading containment (Yong et al., 2009). Surveillance tracks endemicity in the US, Greece, and India (Nordmann et al., 2011). Interventions fail against intercontinental dissemination (Kumarasamy et al., 2010).
Inhibitor Development Failures
Serine carbapenemases like KPC resist avibactam due to structural dynamics, while metallo-enzymes like NDM evade chelators (Nordmann et al., 2011). No universal inhibitors exist for class A, B, and D enzymes. Dual-mechanism blockers remain preclinical (Fair and Tor, 2014).
Detection Model Gaps
Phenotypic tests miss low-expression carbapenemases; genotypic assays overlook novel variants (Alcock et al., 2019). CARD database curates models but lacks real-time evolution tracking (Alcock et al., 2022). Rapid diagnostics lag behind mutation rates in ESKAPE pathogens.
Essential Papers
CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database
Brian Alcock, Amogelang R. Raphenya, Tammy T. Y. Lau et al. · 2019 · Nucleic Acids Research · 3.2K citations
Abstract The Comprehensive Antibiotic Resistance Database (CARD; https://card.mcmaster.ca) is a curated resource providing reference DNA and protein sequences, detection models and bioinformatics t...
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
Eili Klein, Thomas P. Van Boeckel, Elena Martínez et al. · 2018 · Proceedings of the National Academy of Sciences · 3.0K citations
Significance Antibiotic resistance, driven by antibiotic consumption, is a growing global health threat. Our report on antibiotic use in 76 countries over 16 years provides an up-to-date comprehens...
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Kanimozhi Kumarasamy, Mark A. Toleman, Timothy R. Walsh et al. · 2010 · The Lancet Infectious Diseases · 2.9K citations
Antibiotic resistance: a rundown of a global crisis
Bilal Aslam, Wei Wang, Muhammad Arshad et al. · 2018 · Infection and Drug Resistance · 2.4K citations
The advent of multidrug resistance among pathogenic bacteria is imperiling the worth of antibiotics, which have previously transformed medical sciences. The crisis of antimicrobial resistance has b...
Characterization of a New Metallo-β-Lactamase Gene, <i>bla</i> <sub>NDM-1</sub> , and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in <i>Klebsiella pneumoniae</i> Sequence Type 14 from India
Dongeun Yong, Mark A. Toleman, Christian G. Giske et al. · 2009 · Antimicrobial Agents and Chemotherapy · 2.4K citations
ABSTRACT A Swedish patient of Indian origin traveled to New Delhi, India, and acquired a urinary tract infection caused by a carbapenem-resistant Klebsiella pneumoniae strain that typed to the sequ...
Global Spread of Carbapenemase-producing<i>Enterobacteriaceae</i>
Patrice Nordmann, Thierry Naas, Laurent Poirel · 2011 · Emerging infectious diseases · 2.2K citations
Carbapenemases increasingly have been reported in Enterobacteriaceae in the past 10 years. Klebsiella pneumoniae carbapenemases have been reported in the United States and then worldwide, with a ma...
Antibiotics and Bacterial Resistance in the 21st Century
Richard J. Fair, Yitzhak Tor · 2014 · Perspectives in Medicinal Chemistry · 1.9K citations
Dangerous, antibiotic resistant bacteria have been observed with increasing frequency over the past several decades. In this review the factors that have been linked to this phenomenon are addresse...
Reading Guide
Foundational Papers
Start with Yong et al. (2009) for NDM-1 discovery in Klebsiella, Kumarasamy et al. (2010) for epidemiological emergence, Nordmann et al. (2011) for global Enterobacteriaceae spread—these establish genetics and dissemination (2362-2887 citations).
Recent Advances
Alcock et al. (2019, 3193 citations) and Alcock et al. (2022, 1717 citations) provide CARD surveillance; Santajit and Indrawattana (2016) detail ESKAPE mechanisms.
Core Methods
Plasmid conjugation assays (Yong et al., 2009); modified Hodge tests; PCR for bla genes; bioinformatics via CARD ARO ontology (Alcock et al., 2022).
How PapersFlow Helps You Research Carbapenemases
Discover & Search
Research Agent uses searchPapers and exaSearch to find 250M+ OpenAlex papers on 'bla_NDM-1 plasmids', then citationGraph maps spread from Yong et al. (2009) to Nordmann et al. (2011). findSimilarPapers expands to KPC variants from Alcock et al. (2019) CARD models.
Analyze & Verify
Analysis Agent applies readPaperContent on Kumarasamy et al. (2010) to extract NDM-1 epidemiology, verifies spread claims via CoVe against CARD 2023 (Alcock et al., 2022), and runs PythonAnalysis on mutation frequencies with NumPy/pandas. GRADE scores evidence strength for inhibition strategies.
Synthesize & Write
Synthesis Agent detects gaps in OXA-48 inhibitors via contradiction flagging across Fair and Tor (2014), generates exportMermaid diagrams of enzyme classes. Writing Agent uses latexEditText, latexSyncCitations for Yong et al. (2009), and latexCompile for review manuscripts.
Use Cases
"Analyze NDM-1 mutation rates in Klebsiella from 2010-2023 papers"
Research Agent → searchPapers('NDM-1 Klebsiella mutations') → Analysis Agent → readPaperContent(Yong 2009) + runPythonAnalysis(pandas frequency plot) → matplotlib resistance trend graph.
"Write LaTeX review on KPC spread with citations"
Synthesis Agent → gap detection(Nordmann 2011) → Writing Agent → latexEditText(structure) → latexSyncCitations(Alcock 2019) → latexCompile(PDF with figures).
"Find code for carbapenemase detection models"
Research Agent → searchPapers('CARD carbapenemase models') → Code Discovery → paperExtractUrls(Alcock 2022) → paperFindGithubRepo → githubRepoInspect(BioPython scripts for ARG prediction).
Automated Workflows
Deep Research workflow scans 50+ papers on 'carbapenemase plasmids' via searchPapers → citationGraph → structured report with GRADE scores on NDM-1 spread (Yong et al., 2009). DeepScan applies 7-step CoVe to verify inhibitor claims in Fair and Tor (2014) against CARD data. Theorizer generates hypotheses on OXA evolution from Kumarasamy et al. (2010) literature synthesis.
Frequently Asked Questions
What defines carbapenemases?
Carbapenemases are β-lactamases hydrolyzing carbapenems; classes include Ambler A (KPC), B (NDM-1), D (OXA-48) (Nordmann et al., 2011).
What are key detection methods?
CARD uses curated DNA/protein models for genotypic detection; phenotypic CarbaNP tests hydrolytic activity (Alcock et al., 2019).
What are seminal papers?
Yong et al. (2009) characterized bla_NDM-1 (2362 citations); Kumarasamy et al. (2010) mapped its emergence (2887 citations); Nordmann et al. (2011) detailed global spread (2241 citations).
What open problems exist?
Universal inhibitors for metallo-β-lactamases; real-time plasmid tracking; AI models for novel variants beyond CARD (Alcock et al., 2022).
Research Antibiotic Resistance in Bacteria with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Carbapenemases with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers
Part of the Antibiotic Resistance in Bacteria Research Guide